Sherry Yang - Concepedia

Author

Sherry Yang

National Cancer Institute ORCID

Also Known As

S. X. Yang, Sherry X Yang, Sherry X. Yang, Sherry Yang, Yang Sherry, Yang, Sherry

Publications

916

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research Thomas Jefferson University National Institutes of Health

About

Sherry Yang is an author at National Cancer Institute specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	220
2	Business	1	1	50
3	Engineering	1	1	50
4	Health Sciences	1	1	17
5	Management	1	1	50

Sherry Yang

Publications

796

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes Neelima Denduluri, Jennifer A. Low, James J. Lee, Journal of Clinical Oncology	2007	166
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors William L. Dahut, Nehal J. Lakhani, James L. Gulley, Cancer Biology & Therapy	2006	155
Complications in the first year following cataract surgery with and without IOL in infants and older children David A. Plager, Sherry Yang, Daniel E. Neely, Journal of American Association for Pediatric Ophthalmology and Strabismus First YearOphthalmic SurgeryOcular DiseaseOphthalmologyCataract Surgery	2002	113
Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer Sherry Yang, Seth M. Steinberg, Dat Nguyen, Clinical Cancer Research	2008	94
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors Elizabeth Fox, Brigitte C. Widemann, Devang Pastakia, Cancer Chemotherapy and Pharmacology Pharmacodynamic StudyOncologyMedicineP-glycoprotein InhibitorPharmacotherapy	2015	68
Foundation Models for Decision Making: Problems, Methods, and Opportunities Sherry Yang, Ofir Nachum, Yilun Du, arXiv (Cornell University) Artificial IntelligenceEngineeringMachine LearningBehavioral Decision MakingDecision Analysis	2023	50
Circulating biomarkers of bevacizumab activity in patients with breast cancer Neelima Denduluri, Sherry Yang, Arlene Berman, Cancer Biology & Therapy	2008	35
Gene Expression Patterns and Profile Changes Pre- and Post-Erlotinib Treatment in Patients with Metastatic Breast Cancer Sherry Yang, Richard Simon, Antoinette R. Tan, Clinical Cancer Research	2005	35
Comparison of Traditional Superficial Cutaneous Sutures Versus Adhesive Strips in Layered Dermatologic Closures on the Back—A Prospective, Randomized, Split-Scar Study Sherry Yang, David Ozog Dermatologic Surgery	2015	19
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors Kenneth Steadman, Wilfred D. Stein, Thomas Litman, Cell Cycle Cell AdhesionPathologyCancer BiologyTumor BiologyDrug Resistance	2008	17

Page 1